Physician profile
Lawrence Kempf
NPI 1215050455
$24,558.99
in general payments reported to CMS, 2019-2025
44 companies · $5,392 in 2025
The $5,392 reported for 2025 was more than what 98% of Internal Medicine providers received nationally (typical 2025 total: $156).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $3,418 · 2020: $1,171 · 2021: $817 · 2022: $3,077 · 2023: $4,655 · 2024: $6,029 · 2025: $5,392.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $16K · Education: $45.00.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $16,030.89 |
| Education | $45.00 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Astrazeneca Pharmaceuticals LP | $5,052.67 | 2019-2025 | Breztri, Airsupra, Farxiga |
| Abbvie INC. | $4,254.33 | 2020-2025 | |
| Boehringer Ingelheim Pharmaceuticals, INC. | $3,003.94 | 2019-2025 | Jardiance |
| Novo Nordisk INC | $2,133.37 | 2019-2025 | Ozempic, Rybelsus |
| Lilly USA, LLC | $1,411.42 | 2019-2025 | Zepbound, Jardiance, Mounjaro |
| Salix Pharmaceuticals, A Division of Bausch Health US, LLC | $1,167.95 | 2021-2024 | Xifaxan, Trulance |
| Intra-Sana Laboratories | $891.42 | 2023-2025 | Glycate, Reltone 200 Mg, Reltone 400 Mg |
| Phathom Pharmaceuticals, INC. | $824.52 | 2024-2025 | Voquezna |
| Regeneron Healthcare Solutions, INC. | $686.62 | 2019-2020 | |
| Gilead Sciences, INC. | $570.58 | 2019 | |
| Pacira Therapeutics, INC. | $388.05 | 2019 | |
| Sanofi-Aventis U.S. LLC | $351.15 | 2019-2022 | |
| Genzyme Corporation | $312.44 | 2020-2024 | |
| Ardelyx, INC. | $309.21 | 2024-2025 | Ibsrela |
| Almatica Pharma LLC | $300.16 | 2024-2025 | Loreev Xr |
Show all 44 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| E.R. Squibb & Sons, L.L.C. | $271.96 | 2019-2020 | |
| Horizon Therapeutics Plc | $256.80 | 2020-2022 | |
| Xeris Pharmaceuticals, INC. | $206.03 | 2023-2024 | Recorlev, Gvoke Hypopen |
| Pfizer INC. | $171.89 | 2019-2025 | |
| Amgen INC. | $171.11 | 2024-2025 | Otezla, Repatha, Otezla |
| Mallinckrodt Hospital Products INC. | $153.82 | 2025 | Acthar |
| Intuity Medical INC | $151.34 | 2022-2023 | Pogo Automatic Blood Glucose Monitoring System |
| Antares Pharma, INC. | $143.97 | 2023 | Tlando, Xyosted, Nocdurna |
| Bayer Healthcare Pharmaceuticals INC. | $140.67 | 2022 | |
| Astellas Pharma US INC | $128.57 | 2019 | |
| Abbott Laboratories | $123.35 | 2024 | Proclaim |
| Corcept Therapeutics | $114.70 | 2023 | Korlym |
| Amryt Pharma Holdings LTD | $94.95 | 2022 | |
| Nevro Corp. | $83.69 | 2022 | |
| Exact Sciences Corporation | $79.06 | 2025 | Cologuard Collection Kit |
| Genentech USA, INC. | $77.18 | 2020-2022 | |
| Viiv Healthcare Company | $72.45 | 2020-2021 | |
| Currax Pharmaceuticals LLC | $66.70 | 2022-2025 | Contrave, Onzetra Xsail |
| Renalytix Ai, INC. | $61.14 | 2025 | Kidneyintelx Blood Collection Convenience Kit |
| Janssen Pharmaceuticals, INC | $53.59 | 2021-2022 | |
| Azurity Pharmaceuticals, INC. | $50.04 | 2025 | Azmiro |
| Ibsa Pharma INC. | $44.58 | 2020-2021 | |
| Medtronic USA, INC. | $32.14 | 2019 | |
| Glaxosmithkline, LLC. | $31.07 | 2025 | Shingrix |
| Novartis Pharmaceuticals Corporation | $31.01 | 2024 | |
| Paratek Pharmaceuticals, INC. | $30.71 | 2023-2024 | Nuzyra |
| Coala Life INC | $24.28 | 2023 | Coala Heart Monitor |
| Merck Sharp & Dohme LLC | $19.00 | 2020 | |
| Amylyx Pharmaceuticals, INC. | $15.36 | 2023 | Relyvrio |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Lawrence Kempf listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.